Brief: Xspray Receives Notification Of Manufacturing Approval And Provides Update On Clinical Studies

Xspray Pharma publ AB

17/03/2020 16:44

March 17 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY RECEIVES NOTIFICATION OF MANUFACTURING APPROVAL AND PROVIDES UPDATE ON CLINICAL
STUDIES
    * XSPRAY PHARMA AB (PUBL) - PRODUCTION PARTNER NERPHARMA RECEIVED APPROVAL FROM ITALIAN
MEDICINES
AGENCY  FOR FULL-SCALE PRODUCTION FACILITY IN MILAN
    * XSPRAY PHARMA AB (PUBL) - APPROVAL APPLIES TO CLINICAL TRIAL USE OFAMORPHOUS MATERIAL
BASED ON
COMPANY'S HYNAP TECHNOLOGY
    * XSPRAY PHARMA AB (PUBL) - COVID-19 PANDEMIC MAY AFFECT START OF PIVOTAL CLINICAL
BIOEQUIVALENCE
STUDIES

Source text for Eikon:  ID:nWkr85llqf 
Further company coverage:  XSPRAY.ST 

 ((Reuters.Briefs@thomsonreuters.com;))